Intestinal uptake and metabolism of auranofin, a new oral gold-based antiarthritis drug

Science. 1984 Jul 27;225(4660):430-2. doi: 10.1126/science.6429854.

Abstract

Auranofin, 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S-(triethy lphosphine)- gold(I), an experimental antiarthritis pharmaceutical, metabolized in contact with hamster or rat gut wall to yield the deacetylated form of the drug. This product, 1-thio-beta-D-glucopyranosato-S-(triethylphosphine)gold(I), passed through hamster or rat intestinal wall in an everted gut experiment. The metabolite was separated by high-performance liquid chromatography and characterized by retention time, chemical reactivity to yield a known product, and comparison to a synthetic sample of the metabolite.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / metabolism*
  • Auranofin
  • Aurothioglucose / analogs & derivatives*
  • Aurothioglucose / metabolism
  • Chromatography, High Pressure Liquid
  • Cricetinae
  • Gold / analogs & derivatives*
  • Intestinal Absorption*
  • Mesocricetus
  • Rats
  • Rats, Inbred Strains

Substances

  • Anti-Inflammatory Agents
  • Aurothioglucose
  • Auranofin
  • Gold